Idiopathic Pulmonary Fibrosis and Antifibrotic Treatments: Focus on Experimental Studies | Citedby Results | Archives of Pathology & Laboratory Medicine

Skip to Main Content

Skip Nav Destination

Idiopathic Pulmonary Fibrosis and Antifibrotic Treatments: Focus on Experimental Studies

Arch Pathol Lab Med (2018) 142 (9): 1090–1097.

This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.

Exploring the mechanism of Gentiana rigescens Franch. in the treatment of pulmonary fibrosis based on network pharmacology

Hu Ming-xing
Song Yan-Qiu
Gao Peng-Fei
Li Hai-feng
Liu Wei-Hong

SN Applied Sciences (2023) 5 (12)

Female reproductive life span is extended by targeted removal of fibrotic collagen from the mouse ovary

Takashi Umehara
Yasmyn E. Winstanley
Eryk Andreas
Atsushi Morimoto
Elisha J. Williams
Kirsten M. Smith
John Carroll
Mark A. Febbraio
Masayuki Shimada
Darryl L. Russell
Rebecca L. Robker

Science Advances (2022) 8 (24)

Questions of ethical regulation of immunobiological therapy of some occupational lung diseases

L. A. Shpagina
L. A. Panacheva
E. V. Zolotukhina

Perm Medical Journal (2021) 38 (3): 131.

Use of Chou’s 5-Steps Rule to Reveal Active Compound and Mechanism of Shuangshen Pingfei San on Idiopathic Pulmonary Fibrosis

Yeqing Chen
Xinsheng Fan

Current Molecular Medicine (2020) 20 (3): 220.

The effect of core fucosylation-mediated regulation of multiple signaling pathways on lung pericyte activation and fibrosis

Ying Sun
Wei Sun
Ning Yang
Jia Liu
HaiYing Tang
Fengzhou Li
Xiuna Sun
Lili Gao
Fuyang Pei
Jia Liu
Hongli Lin
Wu Taihua

The International Journal of Biochemistry & Cell Biology (2019) 117: 105639.